Searched for
JANSSEN INDIA
Ebola outbreak sparks concern in India, US: Should you be worried? Here's what you need to know about signs, symptoms and preventionEbola in India: The WHO has declared the Ebola outbreak in Congo and Uganda a public health emergency with over 300 cases and 88 deaths. In...- VC fund HealthKois plans $400 million fund for healthcare playHealthKois is aiming at a first close at the end of this year or early 2026. The investments will be deployed over the next four years, wit...
- Indian Men's Hockey team faces 1-5 defeat against Netherlands in South Africa tour finaleThe Indian men's hockey team wrapped up their South Africa tour with a 1-5 defeat against the Netherlands. Despite Abhishek's lone goal, th...
- Covid vaccine after infection give higher protection against illness, show 2 Lancet studiesAccording to the first study, conducted in Brazil, researchers found four vaccines provide additional protection against symptomatic reinfe...
- HealthQuad raises $162 million in final close of second fundThe firm, which counts Medikabazaar, Ekincare, Healthifyme and Qure.ai in its portfolio of invested companies, has got global pharma maker ...
- USIBC appoints four new members to its India Advisory CouncilArundhati Bhattacharya, Chief Executive Officer and Chairperson, Salesforce India who has assumed the role of IAC Chair said the council pl...
- HealthQuad raises Rs 1,134.5 crore towards pre-final close of its second fundThe fund has received commitments from global financial and strategic institutions, including some global pharma and health-tech companies,...
- J&J seeks DCGI's permission for phase-3 clinical trial of its single-dose Covid-19 vaccine“We have submitted an application to the Drugs Controller General of India (DCGI) requesting approval to conduct a bridging clinical study ...
- Johnson & Johnson expects nod for Covid vaccine by early 2021: Paul Stoffels, chief scientific officer, J&JScientists and drug companies across the world are accelerating various treatments and vaccine options to tackle Covid-19, which has claime...
- India's dependency on charitable program for MDR TB drugs not helping, doctors sayIndia's dependency on charity from global drug makers is making it hard for patients to access new antibiotic drugs such as bedaquiline and...
- Offshored Information Technology jobs may not return homeThere is no doubt that India is still a highly attractive and viable option for low-cost labour, albeit not quite as good as it was 15 year...
- Piramal Enterprises to buy 5 Janssen drugs for Rs 1,164 croreThe transaction, which is expected to close this week, marks the Ajay Piramal-led company’s sixth deal in the healthcare space in the past ...
- ‘Miracle drug’ for resistant Tuberculosis to be rolled out for trial todayA ‘miracle drug’ to battle multi-drug resistant tuberculosis MDR-TB, and extensively-drug resistant TB (XDR-TB), will be rolled out on Mond...
- Dishman gets licence from Johnson & Johnson to produce TB drug raw materialDishman Pharmaceuticals and Chemicals today said it has received a licence from Johnson & Johnson to manufacture raw material for a tubercu...
- Dishman Pharma hits 52-week high as drug maker gets licence to manufacture TB medicineDishman Pharmaceuticals and Chemicals surged 16.22 per cent to close at 306.95. The stock closed at a fresh 52-week high on Wednesday.
- Janssen India launches diabetes treatment drugTaken orally once a day, Invokana belongs to a new class of medications which work in a completely different way to other classes of type 2...
- Jubilant Biosys expands drug discovery alliance with JanssenJubilant Biosys will carry out research services and deliver preclinical candidates to Janssen for potential development and commercialisat...
- Sun Pharmaceutical awaits USFDA approval for cancer drug LipodoxAfter gaining market access under a USFDA contingency plan, Sun Pharma is awaiting approval for its cancer drug Lipodox.
- India needs to step up to be a biopharma major, says Boston Consulting Group"India offers several advantages in R&D, but it's behind," said Bart Janssens, a BCG partner and coauthor of the report.
- Hackett stresses on transformation, process improvement in BPOAs the offshore services market matures, transformation and process improvement are likely to play a growing role in companies business pro...
Load More
